Added to YB: 2020-07-25
Pitch date: 2020-07-25
LRMR [bullish]
Larimar Therapeutics, Inc.
-68.98%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform.
Market Cap
$425.9M
Pitch Price
$11.51
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.34
P/E
-1.96
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
LARIMAR THERAPEUTICS INC LRMR
A summary for this pitch has not been created yet.
Read full article (0 min)